Litcius/Paper detail

The Challenges of Third-Generation EGFR Tyrosine Kinase Inhibitors in the Therapy of Advanced NSCLC

Fen Wang, Qing Zhou

2022Journal of Thoracic Oncology16 citationsDOIOpen Access PDF

Topics & Concepts

MedicineTyrosine kinaseOncologyProtein-Tyrosine KinasesTyrosine-kinase inhibitorCancer researchInternal medicineCancerReceptorLung Cancer Treatments and MutationsQuinazolinone synthesis and applicationsCancer therapeutics and mechanisms